青蒿素研发的成功经验对结核病防治的借鉴与启示  

Revelation and reference from successful experience of artemisinin to tuberculosis prevention and control

作　　者：曹玉清 尚希钰 熊一白 纪鑫毓 马艳[1] Cao Yuqing;Shang Xiyu;Xiong Yibai;Ji Xinyu;Ma Yan(Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China)

机构地区：[1]中国中医科学院中医临床基础医学基础所,北京100700

出　　处：《结核与肺部疾病杂志》2023年第6期442-448,共7页Journal of Tuberculosis and Lung Disease

基　　金：国家自然科学基金(82274350);中国中医科学院科技创新工程项目(CI2021A00704,CI2021A01314,CI2021B003)。

摘　　要：青蒿素类抗疟疾药物的发现是全球抗疟药物发展史上的里程碑,其是在科研计划组织下,全国多部门、多学科尽心协作、相互配合取得的重大成果,是继承发扬我国传统医药宝库的成功范例。学习青蒿素研发成功经验的各项措施并汲取经验,对于改进结核病防治工作现状、促进与改善我国目前结核病防控措施均具有十分重要的意义,对如期实现终止结核病流行的目标起到有利的促进作用。The discovery of artemisinin-based antimalarial drugs is a milestone in the history of global antimalarial drug development.It is a major accomplishment achieved by the multi-departmental and multidisciplinary cooperation and mutual cooperation under the organization of scientific research programs,and is a successful example of inheriting and carrying forward the treasure house of traditional medicine in China.Learning the measures of successful experience in artemisinin research and development and drawing experience is important for improving the status quo of tuberculosis preventive treatment,promoting and improving the current tuberculosis prevention and control measures in China,and will play a beneficial role in promoting the goal of ending tuberculosis epidemic as scheduled.

关 键 词：青蒿素类 结核 肺 思考 

分 类 号：R52[医药卫生—内科学]